Rafael Ubeda, MD
Family Medicine · Lake Worth, FLNPI 1699724005
Payments from drug & device makers
Across 99 payments — averaging $33,086 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$3.1M
- GSK$207K
- Novo Nordisk$245
- Astellas Pharma US Inc$218
- Lilly USA, LLC$152
- Abbott$148
- plus $941 from 12 others
Across 8 payments — averaging $231.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$2K
What the payments were for
- Food & beverage$1,94891%
- Education$1959%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 60 | $3,066,675 |
| GSK | 7 | $207,126 |
| Novo Nordisk | 2 | $245 |
| Astellas Pharma US Inc | 3 | $218 |
| Lilly USA, LLC | 5 | $152 |
| Abbott | 1 | $148 |
| Amarin Pharma, Inc. | 2 | $135 |
| AbbVie | 2 | $125 |
| Boehringer Ingelheim | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $116 |
| Sanofi-aventis U.S. LLC | 2 | $107 |
| Regeneron Healthcare Solutions, Inc. | 1 | $106 |
| Esperion Therapeutics, Inc. | 6 | $87 |
| Biogen | 1 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Pfizer | 1 | $22 |
| Ambu Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$239
- Mitra Clip system$148
- Tresiba$125
- JARDIANCE$125
- Vascepa$120
- ELIQUIS$116
- AREXVY$107
- DUPIXENT$106
How this compares
$3,275,505 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 186 | $105,649 |
| JardianceEmpagliflozin | 58 | $39,737 |
| FarxigaDapagliflozin Propanediol | 60 | $38,746 |
| TradjentaLinagliptin | 41 | $24,325 |
| JanuviaSitagliptin Phosphate | 43 | $23,806 |
| EntrestoSacubitril/Valsartan | 29 | $19,937 |
| XareltoRivaroxaban | 28 | $19,015 |
| OzempicSemaglutide | 16 | $17,854 |
| Advair HfaFluticasone Propion/Salmeterol | 41 | $14,702 |
| AptiomEslicarbazepine Acetate | 12 | $14,272 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 12 | $10,351 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 139 | $10,153 |
| LinzessLinaclotide | 19 | $9,645 |
| BrilintaTicagrelor | 21 | $9,080 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 373 | $7,395 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $22 | $105,649186 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $125 | $69,237110 claims |
| Novo NordiskOzempic | $245 | $17,85416 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $107 | $14,86069 claims |
| AbbVieLinzess, Lumigan | $125 | $12,36330 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Lake Worth
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.